BTI
LEGN icon

Blue Trust Inc’s Legend Biotech LEGN Stock Holding History

Blue Trust Inc’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4K Buy
+83
New +$2.24K ﹤0.01% 2152
2025
Q4 		– Sell
-33
Closed -$1.08K – 2650
2025
Q3 		$1.08K Hold
33
– – ﹤0.01% 2306
2025
Q2 		$1.17K Sell
33
-331
-91% -$10.7K ﹤0.01% 2221
2025
Q1 		$12.4K Buy
364
+43
+13% +$1.54K ﹤0.01% 1808
2024
Q4 		$10.4K Sell
321
-41
-11% -$1.7K ﹤0.01% 1825
2024
Q3 		$16K Sell
362
-452
-56% -$24.1K ﹤0.01% 2032
2024
Q2 		$45.7K Buy
814
+806
+10,075% +$37.2K ﹤0.01% 1290
2024
Q1 		$449 Sell
8
-211
-96% -$12.7K ﹤0.01% 2020
2023
Q4 		$14K Buy
219
+199
+995% +$12.6K ﹤0.01% 1453
2023
Q3 		$1K Buy
+20
New +$1.39K ﹤0.01% 1931
2023
Q2 		– Sell
-193
Closed -$10K – 2307
2023
Q1 		$10K Buy
193
+85
+79% +$4.16K ﹤0.01% 1606
2022
Q4 		$5K Buy
+108
New +$5.23K ﹤0.01% 1728

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Blue Trust Inc's LEGN Position: Q2 2026 in Review

Blue Trust Inc opened a new position in Legend Biotech (LEGN) in Q2 2026: 83 shares worth $2.4K. The stake represents ﹤0.01% of the portfolio and ranks #2152 among its holdings. This is a return to the name: Blue Trust Inc previously reported a position in LEGN as recently as Q3 2025.

Blue Trust Inc first reported a position in LEGN in Q4 2022 and has held it in 12 quarters since. The position peaked at $45.7K in Q2 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Blue Trust Inc held 83 shares of Legend Biotech worth $2.4K as of Q2 2026.
  • Legend Biotech was a new Blue Trust Inc position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2152 holding.
  • Blue Trust Inc first reported a position in Legend Biotech in Q4 2022 and has held it in 12 quarters since.
  • Blue Trust Inc's Legend Biotech position peaked at $45.7K in Q2 2024.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.